Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

French group develops new inhibitors of HIV-1 protease dimerization

July 10, 1998

AMD-3100: a potent chemokine CXCR4 antagonist enters clinical testing

July 10, 1998

Anti-HIV peptide T-22 acts as a CXCR4 receptor antagonist

July 10, 1998

Enzo discovery paves the way for antisense therapy of AIDS

July 10, 1998

Chiron updates HIV product development

July 10, 1998

An overview of antiviral intervention strategies for HIV therapy

July 10, 1998

AMD-3465, a selective CXCR4 antagonist with potent anti-HIV activity

July 9, 1998

Lodenosine phase I data supports combination studies

July 9, 1998

Japanese investigators study HIV protease inhibitor with activity in drug-resistant virus

July 9, 1998

New hope for eliminating mother-to-child transmission of HIV

July 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...